HighTide Therapeutics, Inc.

SEHK:2511 Stok Raporu

Piyasa değeri: HK$622.9m

HighTide Therapeutics Yönetim

Yönetim kriter kontrolleri 1/4

HighTide Therapeutics' CEO is Liping Liu, appointed in Feb 2018, has a tenure of 6.75 years. total yearly compensation is CN¥14.66M, comprised of 24.1% salary and 75.9% bonuses, including company stock and options. directly owns 0.96% of the company’s shares, worth HK$6.00M. The average tenure of the management team and the board of directors is 2.8 years and 1.8 years respectively.

Anahtar bilgiler

Liping Liu

İcra Kurulu Başkanı

CN¥14.7m

Toplam tazminat

CEO maaş yüzdesi24.1%
CEO görev süresi6.8yrs
CEO sahipliği1.0%
Yönetim ortalama görev süresi2.8yrs
Yönetim Kurulu ortalama görev süresi1.8yrs

Son yönetim güncellemeleri

Recent updates

We're A Little Worried About HighTide Therapeutics' (HKG:2511) Cash Burn Rate

Oct 05
We're A Little Worried About HighTide Therapeutics' (HKG:2511) Cash Burn Rate

Is HighTide Therapeutics (HKG:2511) In A Good Position To Invest In Growth?

Jun 21
Is HighTide Therapeutics (HKG:2511) In A Good Position To Invest In Growth?

CEO Tazminat Analizi

Liping Liu'un ücretlendirmesi HighTide Therapeutics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-CN¥601m

Mar 31 2024n/an/a

-CN¥770m

Dec 31 2023CN¥15mCN¥4m

-CN¥939m

Sep 30 2023n/an/a

-CN¥803m

Jun 30 2023n/an/a

-CN¥666m

Mar 31 2023n/an/a

-CN¥428m

Dec 31 2022CN¥7mCN¥4m

-CN¥190m

Dec 31 2021CN¥7mCN¥3m

-CN¥221m

Tazminat ve Piyasa: Liping's total compensation ($USD2.07M) is above average for companies of similar size in the Hong Kong market ($USD234.60K).

Tazminat ve Kazançlar: Liping's compensation has increased whilst the company is unprofitable.


CEO

Liping Liu (54 yo)

6.8yrs

Görev süresi

CN¥14,663,000

Tazminat

Dr. Liping Liu has been the Chief Executive Officer and Executive Director of HighTide Therapeutics, Inc. since February 28, 2018 and its chairwoman since December 22, 2023 She has been the Chief Executive...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Liping Liu
CEO & Chairwoman6.8yrsCN¥14.66m0.96%
HK$ 6.0m
Meng Yu
Deputy GM & Executive Director7.4yrsCN¥10.83m0.34%
HK$ 2.1m
Koon Yin Sim
Chief Financial Officer1.9yrsVeri yokVeri yok
Leigh Anne MacConell
Chief Development Officer3.8yrsVeri yokVeri yok
Yu Li
VP & Joint Company Secretary1.5yrsVeri yokVeri yok
Pik Man Chu
Joint Company Secretaryless than a yearVeri yokVeri yok

2.8yrs

Ortalama Görev Süresi

50.5yo

Ortalama Yaş

Deneyimli Yönetim: 2511's management team is considered experienced (2.8 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Liping Liu
CEO & Chairwoman6.8yrsCN¥14.66m0.96%
HK$ 6.0m
Meng Yu
Deputy GM & Executive Director1.5yrsCN¥10.83m0.34%
HK$ 2.1m
Gwen A. Melincoff
Member of the Scientific Advisory Boardno dataVeri yokVeri yok
Bo Tan
Independent Non-Executive Directorless than a yearCN¥4.00kVeri yok
Lawrence Goldkind
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Xun Zhu
Non-Executive Director4yrsCN¥1.84m0.17%
HK$ 1.0m
Li Jin
Independent Non-Executive Directorless than a yearCN¥4.00kVeri yok
Kris Kowdley
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Feng Jiang
Non-Executive Director2yrsVeri yokVeri yok
Lixiong Ma
Non-Executive Director3yrsCN¥8.90m0.19%
HK$ 1.2m
Tak Wai Hung
Independent Non-Executive Directorless than a yearCN¥4.00kVeri yok
Adrian M. Di Bisceglie
Member of Scientific Advisory Boardno dataVeri yokVeri yok

1.8yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 2511's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.